Allogene CFO Geoffrey Parker to retire effective Nov. 6
Allogene Therapeutics said CFO Geoffrey Parker will retire effective Nov. 6, adding to leadership changes after Zachary Roberts was elevated to chief executive.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Allogene CFO Geoffrey Parker to retire Nov. 6, 2026
Allogene said Executive Vice President and Chief Financial Officer Geoffrey Parker will retire from the company effective Nov. 6, 2026.